Tuesday, February 11, 2014 1:14:21 PM
http://fileaproofofclaim.com/atrinsic-bankruptcy-atrinsic-inc-files-chapter-11-bankruptcy-protection/
"Just prior to the Petition Date, the Debtor negotiated with its two primary secured creditors, Iroquois Master Fund Ltd. (“Iroquois”) and Hudson Bay Master Fund, Ltd. (“Hudson”), the terms of an Order authorizing the use of cash collateral and a Plan of Reorganization Support Agreement. The PSA provides, among other things, for the filing of a plan of reorganization no later than June 30, 2012 which will provide for a distribution to all classes of claims and interests and the Debtor intends to expeditiously seek confirmation of a Plan of Reorganization"
Iroquis Master Fund and Hudson Bay Master Fund are the major holders of atrinsic. If I'm not wrong they own the 92% of atrinsic shares. With this company we can see A relation between Mr.Giordano and Hudson and Iroquis. The accept the plan and it seems that they work closely...
"Just prior to the Petition Date, the Debtor negotiated with its two primary secured creditors, Iroquois Master Fund Ltd. (“Iroquois”) and Hudson Bay Master Fund, Ltd. (“Hudson”), the terms of an Order authorizing the use of cash collateral and a Plan of Reorganization Support Agreement. The PSA provides, among other things, for the filing of a plan of reorganization no later than June 30, 2012 which will provide for a distribution to all classes of claims and interests and the Debtor intends to expeditiously seek confirmation of a Plan of Reorganization"
Iroquis Master Fund and Hudson Bay Master Fund are the major holders of atrinsic. If I'm not wrong they own the 92% of atrinsic shares. With this company we can see A relation between Mr.Giordano and Hudson and Iroquis. The accept the plan and it seems that they work closely...
Recent PTIX News
- Protagenic Therapeutics Completes Phytanix Separation, Strengthens Balance Sheet and Repositions the Company Around PT00114 • ACCESS Newswire • 03/17/2026 12:00:00 PM
- Protagenic Therapeutics Upgrades from OTC Pink to OTCQB Venture Market • ACCESS Newswire • 03/10/2026 12:00:00 PM
- Results from Phase 1 Multiple-Dose Study of PT00114 • ACCESS Newswire • 12/09/2025 01:46:00 PM
- Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice • ACCESS Newswire • 11/27/2025 08:45:00 AM
- Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study • ACCESS Newswire • 11/13/2025 01:22:00 PM
- Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates • GlobeNewswire Inc. • 07/30/2025 12:30:00 PM
- Nasdaq Top 5 Premarket Losers • IH Market News • 05/20/2025 12:47:37 PM
- Protagenic Therapeutics Soars 190% on Merger to Launch Neuroactive Biopharma Firm • IH Market News • 05/19/2025 02:28:09 PM
- Nasdaq Top 5 Premarket Gainers • IH Market News • 05/19/2025 01:07:08 PM
